Insider Transactions in Q1 2025 at Regenxbio Inc. (RGNX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2025
|
Kenneth T. Mills |
BUY
Exercise of conversion of derivative security
|
Direct |
30,752
+6.08%
|
$92,256
$3.76 P/Share
|
|
Feb 01
2025
|
Olivier Danos Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,452
-2.35%
|
$43,616
$8.07 P/Share
|
|
Feb 01
2025
|
Steve Pakola Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,263
-2.44%
|
$42,104
$8.07 P/Share
|
|
Feb 01
2025
|
Patrick J. Christmas Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,700
-2.92%
|
$37,600
$8.07 P/Share
|
|
Jan 02
2025
|
Patrick J. Christmas Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,395
-6.62%
|
$79,765
$7.73 P/Share
|
|
Jan 02
2025
|
Curran Simpson Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
98,912
+27.79%
|
-
|
|
Jan 02
2025
|
Curran Simpson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,917
-7.01%
|
$83,419
$7.73 P/Share
|
|
Jan 02
2025
|
Olivier Danos Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59,347
+20.38%
|
-
|
|
Jan 02
2025
|
Olivier Danos Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,630
-6.82%
|
$88,410
$7.73 P/Share
|
|
Jan 02
2025
|
Steve Pakola Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
64,293
+22.94%
|
-
|
|
Jan 02
2025
|
Steve Pakola Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,891
-8.39%
|
$97,237
$7.73 P/Share
|